nuwellis.com (NUWE) Kapitallashuvning sof aktivlarga nisbati

Nuwellis Inc - NUWE emitenti grafik logotipi

Surunkali naqd pul yetishmovchiligi va texnologiyalarni joriy etishning sekinligi Nuwellis, Inc. (NUWE) kompaniyasining erkin pul oqimining (FCF) bashorat qilinuvchanligini yo'qqa chiqaradi. GURU.Markets platformasi grafigidagi bozor qiymatining buxgalteriya qiymatiga nisbati (market-to-book ratio) joriy tendentsiyani namoyish etadi, bunda -0.18 belgisi ushbu metrikani qayd etadi. Tijorat joriy etishning past sur'atlari xarajatlarni oshirmoqda, zavodlarda plastikni qayta ishlash va energiyani tejashni joriy etish esa joriy ESG standartlariga mos keladi.

Nuwellis Corp (NUWE) - Balans qiymatiga nisbatan bozor qiymati 04.07.2022dan 29.10.2026gacha

Nuwellis Inc (NUWE) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- aksiya kursi va ekspertlarning narx prognozi:
Aksiya narxi Nuwellis, Inc.|NUWE - Oʻrtacha prognoz narxi
- bozor kapitallashuvi tafsilotlari:
Bozor bahosi CHF Solutions|NUWE - Biznesning umumiy qiymati
- balans kapitallashuvi ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Nuwellis|NUWE - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati nuwellis.com|NUWE - Kompaniya aktivlari
- kompaniyaning jami qarzi va likvidligi ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati Nuwellis, Inc.|NUWE - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati CHF Solutions|NUWE - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati CHF Solutions|NUWE - Uzoq muddatli majburiyatlar|Kompaniyaning qisqa muddatli qarzlari Nuwellis|Tezkor likvidlik ko‘rsatkichi nuwellis.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
NUWE - Sof foyda
Kompaniyaning dastlabki tahlili:Nuwellis, Inc.
Nuwellis Inc ishlab chiqargan mahsulot

Aquadex tizimlari yetkazib berish orqali o'z klinikalari tarmog'ini kengaytirayotgan Nuwellis, Inc. uchun ushbu ko'rsatkich kapital sifatini baholash vositasi bo'lib xizmat qiladi. Ushbu metrika kompaniyaning bozor qiymatining uning sof aktivlari qiymatiga nisbati sifatida hisoblanadi. Joriy bozor kapitalizatsiyasini balans qiymatiga nisbatan tahlil qilish orqali investor biznes uchun to'langan premium miqdorini aniqlaydi. Yuqori qiymatlar bozor kutuvlarining ortiqchaligidan dalolat beradi, past koeffitsiyent esa kompaniyaning moddiy aktivlari qadrsizlanganini ko'rsatadi.

Raqobatdosh kompaniyalar

DXCM: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti penumbrainc.com (PEN)|Kapitallashuvning sof aktivlarga nisbati NOVT|HAE (Haemonetics Corp) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati INSP|PRCT (Procept) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati CNMD (CONMED Corporation)|pulsebiosciences.com (PLSE) - Bozor qiymatining balans qiymatiga koeffitsiyenti|INMD - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati PMI (Picard Medical Corp)|SRDX: Bozor kapitallashuvining balans qiymatiga nisbati|Senseonics Holdings, Inc. (SENS) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati NeuroPace, Inc.|Tactile Systems Technology Inc. - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati SNWV|OM - Bozor qiymatining balans qiymatiga koeffitsiyenti|Electromed - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati LENSAR Inc LNSR|RCEL: Kapitallashuvning sof aktivlarga nisbati|Profound Medical Corp. - Bozor kapitallashuvining balans qiymatiga multiplikatori|BDMD: Bozor kapitallashuvining balans qiymatiga nisbati|EDAP - Balans qiymatiga nisbatan bozor kapitallashuvi|APYX (Apyx Medical Corp) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati IceCure Medical, Ltd. (ICCM)|Kapitallashuvning sof aktivlarga nisbati LUNG (Pulmonx Corporation)|TELA (telabio.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati CytoSorbents Corporation CTSO|SRTS - Kapitallashuvning sof aktivlarga nisbati|Zynex Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti electroCore, Inc.|RBOT: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati IINN|ICU (SeaStar Medical) - Bozor kapitallashuvining balans qiymatiga nisbati|IRIDEX Corp. (IRIX) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati INBS|Kapitallashuvning sof aktivlarga nisbati beyondair.net XAIR|Bozor kapitallashuvining balans qiymatiga nisbati PFSA (Profusa Inc)|Bozor kapitallashuvining balans qiymatiga nisbati STRATA Skin Sciences Inc. SSKN|GCTK - Bozor qiymatining balans qiymatiga nisbati|NAOV: Bozor qiymatining balans qiymatiga nisbati|VERO (Venus Concept Corp) - Kapitallashuvning sof aktivlarga nisbati|Aethlon Medical Corp - Balans qiymatiga nisbatan bozor qiymati|ASXC (Asensus Surgical Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti avinger.com AVGR|Bozor qiymatining balans qiymatiga nisbati biosig.com (BSGM)|Cutera Inc. (CUTR) - Bozor qiymatining xususiy kapitalga nisbati|Know Labs Corp - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Inari Medical Corp NARI|Nevro Corp. - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi ReShape Lifesciences RSLS|Silk Road Medical (SILK) - Bozor qiymatining balans qiymatiga nisbati